How long does Escaline last?

The total duration of Escaline via oral is 8 hours to 12 hours. Onset typically occurs within 1.5 hours to 2 hours.

Escaline — SubstanceWiki

Escaline

Substituted phenethylamines · Psychedelic

Psychedelic(Substituted phenethylamines)

Quick Dosage

oral50–100 mg (common)

Total duration (oral)8hr–12hr

View full details

Escaline (3,5-dimethoxy-4-ethoxyphenethylamine) is a psychedelic phenethylamine and the 4-ethoxy analog of mescaline — a member of the broad family of trimethoxyphenethylamine-related compounds in which one or more of mescaline's methoxy groups is replaced with longer alkoxy chains. Escaline was synthesized and characterized by Alexander Shulgin, documented in PiHKAL (1991), as part of his systematic exploration of mescaline structural modifications.

At active doses (30–75 mg), escaline produces a full psychedelic experience of 6–10 hours with rich visual phenomena, emotional depth, sensory enhancement, and the warm, "soft" psychedelic quality associated with mescaline and its analogs. Community reports describe escaline as producing a particularly open, emotionally available state — less visually aggressive than high-dose 2C-B, more empathogenic than typical LSD experiences, with a pacing and character that experienced users often describe as among the more beautiful and gentle full-dose psychedelic experiences available.

The replacement of the 4-methoxy group of mescaline with a 4-ethoxy group produces a 5–8 fold increase in 5-HT2A receptor affinity according to published data, making escaline substantially more potent than mescaline by weight while sharing its fundamental pharmacological character. The community experience with escaline, while smaller than for mainstream psychedelics, is broadly consistent with these pharmacological predictions — an experienced phenethylamine user finding escaline to be a somewhat more potent and moderately longer-duration variant on the mescaline experiential theme.

How It Feels

The come-up begins within forty-five minutes to an hour as a soft, spreading warmth that starts in the abdomen and gradually suffuses the entire body. There is a quality of gentleness to the onset that sets the tone for the entire experience. The stomach may murmur quietly in protest, but significant nausea is uncommon. The first perceptual changes appear as a subtle enrichment of color -- greens become deeper and more luminous, blues acquire a velvety depth, and warm tones glow with soft intensity. There is an almost nostalgic quality to the visual shift, as though the world is being viewed through the lens of a cherished memory.

As the experience develops over the next ninety minutes, the visual component unfolds into a gentle, immersive psychedelic state. Colors are richly saturated with a distinctly natural palette -- the deep greens of forest canopy, the warm golds of ripe grain, the complex browns and ambers of earth and bark. Surfaces breathe with slow, organic rhythms. Geometric patterns, when they appear, take the form of flowing, rounded shapes that echo natural structures: spiraling shells, branching rivers, radiating flower petals. The visual character is unmistakably related to mescaline, sharing its earthy, organic aesthetic, though at a lower intensity that makes the experience more accessible. Closed-eye visuals present as slowly shifting kaleidoscopic arrangements in warm, saturated colors.

The headspace is warm, open, and emotionally generous. There is a pronounced empathogenic quality -- a softening of interpersonal boundaries and a heightened capacity for emotional connection that makes conversations feel unusually honest and tender. The mind is clear and unhurried, capable of reflection without compulsion. There is little anxiety, little cognitive distortion, and little of the analytical intensity that characterizes the more cerebral phenethylamines. Instead, the experience is defined by a steady, reliable warmth -- an emotional tone of quiet joy and grateful presence. Music is beautifully enhanced, and natural environments feel particularly resonant. The body is comfortable and relaxed, with a gentle heaviness in the limbs that encourages stillness without demanding it.

The duration spans six to ten hours, with a long, gentle plateau and a slow, graceful descent. The comedown is smooth and leaves behind an afterglow of emotional openness and visual sensitivity that may persist well into the following day. The aftermath is clean and restorative. Escaline reads as one of the most forgiving and emotionally nourishing members of the mescaline family -- a substance that gives generously and asks almost nothing in return.

Interactions

Substance	Status	Note
3-FMA	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-MMC	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
8-Chlorotheophylline	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Adrafinil	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Anandamide	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
APICA	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Atropa belladonna	Caution	Unpredictable compounding of hallucinogenic effects with anticholinergic delirium
Benzydamine	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Bromantane	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Cannabidiol	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Datura	Caution	Unpredictable compounding of hallucinogenic effects with anticholinergic delirium
Dichloropane	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Diphenhydramine	Caution	Unpredictable compounding of hallucinogenic effects with anticholinergic delirium
Ephedrine	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Harmala alkaloid	Caution	MAOIs dramatically potentiate psychedelics; drastically reduce dose and exercise extreme caution
Hexedrone	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Methcathinone	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Nicotine	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Oxiracetam	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Peganum harmala	Caution	MAOIs dramatically potentiate psychedelics; drastically reduce dose and exercise extreme caution
Phenylpiracetam	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Rhodiola Rosea	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Cannabis	Uncertain	—
1,3-Butanediol	Low Risk & Synergy	Cross-tolerance exists; effects compound
25E-NBOH	Low Risk & Synergy	Cross-tolerance exists; effects compound
2C-T	Low Risk & Synergy	Cross-tolerance exists; effects compound
2C-T-2	Low Risk & Synergy	Cross-tolerance exists; effects compound
2C-T-21	Low Risk & Synergy	Cross-tolerance exists; effects compound
2C-T-7	Low Risk & Synergy	Cross-tolerance exists; effects compound
3-Cl-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-HO-PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-HO-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-MeO-PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-MeO-PCMo	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-MeO-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
4-MeO-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
Allylescaline	Low Risk & Synergy	Cross-tolerance exists; effects compound
Ayahuasca	Low Risk & Synergy	Cross-tolerance exists; effects compound
Deschloroketamine	Low Risk & Synergy	Produces unique synergistic effects; often combined
DET	Low Risk & Synergy	Cross-tolerance exists; effects compound
Diphenidine	Low Risk & Synergy	Produces unique synergistic effects; often combined
DiPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
DOM	Low Risk & Synergy	Cross-tolerance exists; effects compound
DPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
Efavirenz	Low Risk & Synergy	Cross-tolerance exists; effects compound
Ephenidine	Low Risk & Synergy	Produces unique synergistic effects; often combined
EPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
HXE	Low Risk & Synergy	Produces unique synergistic effects; often combined
Ibogaine	Low Risk & Synergy	Cross-tolerance exists; effects compound
Inhalants	Low Risk & Synergy	Produces unique synergistic effects; often combined
Memantine	Low Risk & Synergy	Produces unique synergistic effects; often combined
MET	Low Risk & Synergy	Cross-tolerance exists; effects compound
Methallylescaline	Low Risk & Synergy	Cross-tolerance exists; effects compound
MiPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
MPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
MXiPr	Low Risk & Synergy	Produces unique synergistic effects; often combined
O-PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
Psilocybin Mushrooms	Low Risk & Synergy	Cross-tolerance exists; effects compound
Lorazepam	Low Risk & Decrease	Depressants dull psychedelic effects; benzodiazepines are commonly used as trip-killers

Showing 60 key interactions out of 79 total.

Toxicity & Safety

General Safety Profile

Escaline has no documented fatalities from direct pharmacological action. Its mescaline-analog structure places it within a class with historically good acute safety records at typical doses. The well-characterized 5-HT2A mechanism without significant monoamine releasing activity keeps acute physiological toxicity risks low.

Cardiovascular

Mild sympathomimetic effects — modest tachycardia and blood pressure elevation — are expected. Less pronounced than with stimulant-forward phenethylamines like 2C-I.

Duration

The 6–10 hour duration is a physiological commitment. Sustained effects over this timeframe require corresponding preparation and recovery time.

Psychological Risks

Standard psychedelic risk profile: acute anxiety/panic at higher doses, potential for psychosis precipitation in vulnerable individuals, integration challenges.

Regulatory Note

Escaline was prohibited in Belgium under the New Psychoactive Substances Act as of November 26, 2016, reflecting regulatory attention to mescaline analogs in European jurisdictions.

Drug Interactions

MAOIs: Contraindicated
Lithium: Contraindicated
Cannabis: May amplify and extend effects

Addiction Potential

not habit-forming

Overdose Information

Fatal overdose from Escaline alone, at doses within the typical recreational range, is extremely unlikely based on the available evidence for classical psychedelics. The therapeutic index for most psychedelics is very wide.

However, psychological emergencies can occur and require appropriate response:

Severe anxiety, panic, or psychotic episodes
Dangerous behavior due to impaired reality testing
Self-harm in the context of a distressing experience

Emergency management: If someone is experiencing a severe adverse reaction, move them to a calm, quiet environment. Speak reassuringly. Do not restrain unless there is immediate danger. Benzodiazepines (if available and the person is conscious and able to swallow) can reduce acute anxiety. If psychotic symptoms, self-harm risk, or medical distress is present, seek emergency medical attention.Medical attention: Seek help immediately for seizures, extremely elevated body temperature, signs of serotonin syndrome (agitation, tremor, diarrhea, rapid heart rate), or if the substance consumed is uncertain.

Full	almost immediately after ingestion
Half	3 days
Zero	7 days

Escaline

Quick Dosage

Dosage

oral

Duration

oral

How It Feels

Subjective Effects

Physical Effects

Physical(5)

Tactile(1)

Cognitive & Perceptual Effects

Visual(12)

Pharmacology

Mechanism of Action

4-Ethoxy Substitution Effects

Comparison to Mescaline

Duration

Detection Methods

Urine Detection

Blood and Serum Detection

Standard Drug Panel Inclusion

Confirmatory Methods

Reagent Testing (Harm Reduction)

Interactions

History

Development and PiHKAL

Community Reports

Legal Status

Harm Reduction

Dose Reference

Allow a Full Day

Prepare for Emotional Depth

Nausea

Dangerous Combinations

Toxicity & Safety

General Safety Profile

Cardiovascular

Duration

Psychological Risks

Regulatory Note

Drug Interactions

Addiction Potential

Overdose Information

Tolerance

Cross-tolerances

Legal Status

Experience Reports (3)

Tips (6)

Community Discussions (2)

See Also

References (6)

Frequently Asked Questions

Cognitive(13)

Transpersonal(3)